Original Article
Clinicopathological features of adenosquamous carcinoma of the lung in elderly patients
Yang Tianyu, Sheng Renming, Lou Xiaoli, Xu Jingze, Shuai Lixiong, Cao Zhifei, Zhang Yongsheng
Published 2022-05-14
Cite as Chin J Geriatr, 2022, 41(5): 555-559. DOI: 10.3760/cma.j.issn.0254-9026.2022.05.010
Abstract
ObjectiveTo investigate the clinicopathological features, immunohistochemical phenotypes and molecular characteristics of adenosquamous carcinoma of the lung(ASC)in elderly patients.
MethodsClinical data of 72 ASC patients in the Department of Pathology, The Second Affiliated Hospital of Soochow University from January 2009 to December 2020 were retrospectively analyzed, and 48 patients aged ≥60 years were selected.Clinical manifestations, imaging findings, histopathological and immunohistochemical characteristics were collected, and gene mutations were detected by the amplification refractory mutation system(ARMS-PCR).
ResultsThere were 48 patients including 32 males and 16 females with a mean age of 70 years(range: 60-84 years). The maximum diameters of the tumors ranged from 0.3 to 9.0 cm(mean: 2.8 cm). Microscopically, the tumors contained two components, squamous cell carcinoma and adenocarcinoma, with the squamous cell carcinoma tissue showing intercellular bridges and the adenocarcinoma tissue showing papillary, acinar or tubular structures.Immunohistochemistry assays detected varying expression levels of CK7(30/31), CK5/6(20/28), TTF1(12/31), P40(15/17), and P63(12/13). Molecular testing showed that the EGFR mutation rate was 58.8%(10/17)and the ALK fusion mutation rate was 5.9%(1/17), while ROS1 and MET mutations were not detected.All 48 patients underwent surgical resection.
ConclusionsASC cases are relatively rare and prone to misdiagnosis.The diagnosis requires the combination of HE morphology, immunohistochemistry and imaging examination, and surgery is the main treatment option.The mutation rate of the EGFR gene is relatively high in ASC patients.
Key words:
Lung neoplasms; Pathology, clinical; DNA mutational analysis
Contributor Information
Yang Tianyu
Department of Pathology, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China
Sheng Renming
Department of Pathology, the First People's Hospital of Changshu City, Changshu 215500, China
Lou Xiaoli
Department of Pathology, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China
Xu Jingze
Department of Pathology, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China
Shuai Lixiong
Department of Pathology, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China
Cao Zhifei
Department of Pathology, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China
Zhang Yongsheng
Department of Pathology, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China